Belarus vs Singapore: The number of people with susceptibility test result for rifampicin
Belarus
1,032
in 2021
Singapore
1,051
in 2021
Belarus rank
66th
Singapore rank
65th
The number of people with susceptibility test result for rifampicin over time
- Belarus
- Singapore
How they compare
Singapore currently reports 1,051 against 1,032 in Belarus, a difference of 19.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belarus ahead.
Belarus ranks 66th and Singapore ranks 65th of 155 countries.
Across the 2 decades both report, Belarus averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Belarus | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,570 | 1,090 | 479.33 | Belarus |
| 2020s | 1,024 | 1,058 | 35 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belarus or Singapore?
- Singapore, at 1,051 against 1,032 in Belarus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belarus and Singapore?
- 19, with Singapore ahead.
- How many years of comparable data are there for Belarus and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Belarus and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 66th and Singapore ranks 65th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.